olprinone has been researched along with Pulmonary Hypertension in 6 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine acute effects of olprinone hydrochloride (CAS 106730-54-0, Coretec) on pulmonary hypertension, hypoxic pulmonary hypertension was produced in 6 adult Beagle dogs." | 7.70 | Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension. ( Amitani, S; Kakura, H; Koga, M; Misumi, K; Miura, N; Miyahara, K; Sakamoto, H; Sohara, H, 2000) |
| "In the present study in dogs, we compared with aminophylline the spasmolytic effects of olprinone, a novel phosphodiesterase 3 inhibitor, on serotonin-induced pulmonary hypertension (PH) and bronchoconstriction." | 7.70 | A comparison of the spasmolytic effects of olprinone and aminophylline on serotonin-induced pulmonary hypertension and bronchoconstriction with or without beta-blockade in dogs. ( Hashimoto, Y; Hirota, K; Ishihara, H; Kudo, T; Matsuki, A; Yoshioka, H, 2000) |
| "Milrinone administered through inhalation is an emerging method aimed at specifically reducing pulmonary hypertension without affecting systemic pressures." | 3.80 | A specific and sensitive HPLC-MS/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients. ( Denault, AY; Gavra, P; Litalien, C; Nguyen, AQ; Theoret, Y; Varin, F, 2014) |
| "Twenty-six infants with pulmonary hypertension undergoing ventricular septum defect repair were retrospectively allocated to milrinone group (n= 13)and olprinone group(n=13)." | 3.79 | [Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery]. ( Izumi, K; Jimi, N; Mizuno, K; Sakimura, S; Sumiyoshi, R; Yoshino, J, 2013) |
| " After the induction of anesthesia with sevoflurane, fentanyl, and vecuronium, continuous infusion of alprostadil and olprinone was started." | 3.73 | [Anesthetic management for an infant with tetralogy of fallot with absent pulmonary valve]. ( Fukuda, K; Ishii, H; Tanaka, T; Yamashita, H, 2005) |
| "To examine acute effects of olprinone hydrochloride (CAS 106730-54-0, Coretec) on pulmonary hypertension, hypoxic pulmonary hypertension was produced in 6 adult Beagle dogs." | 3.70 | Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension. ( Amitani, S; Kakura, H; Koga, M; Misumi, K; Miura, N; Miyahara, K; Sakamoto, H; Sohara, H, 2000) |
| "In the present study in dogs, we compared with aminophylline the spasmolytic effects of olprinone, a novel phosphodiesterase 3 inhibitor, on serotonin-induced pulmonary hypertension (PH) and bronchoconstriction." | 3.70 | A comparison of the spasmolytic effects of olprinone and aminophylline on serotonin-induced pulmonary hypertension and bronchoconstriction with or without beta-blockade in dogs. ( Hashimoto, Y; Hirota, K; Ishihara, H; Kudo, T; Matsuki, A; Yoshioka, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakimura, S | 1 |
| Yoshino, J | 1 |
| Izumi, K | 1 |
| Jimi, N | 1 |
| Sumiyoshi, R | 1 |
| Mizuno, K | 1 |
| Gavra, P | 1 |
| Nguyen, AQ | 1 |
| Theoret, Y | 1 |
| Litalien, C | 1 |
| Denault, AY | 1 |
| Varin, F | 1 |
| Komasawa, N | 1 |
| Noma, H | 1 |
| Sugi, T | 1 |
| Sukenaga, N | 1 |
| Tokuoka, T | 1 |
| Kakiuchi, H | 1 |
| Tanaka, T | 1 |
| Yamashita, H | 1 |
| Ishii, H | 1 |
| Fukuda, K | 1 |
| Kakura, H | 1 |
| Miyahara, K | 1 |
| Amitani, S | 1 |
| Sohara, H | 1 |
| Koga, M | 1 |
| Sakamoto, H | 1 |
| Misumi, K | 1 |
| Miura, N | 1 |
| Hashimoto, Y | 1 |
| Hirota, K | 1 |
| Yoshioka, H | 1 |
| Kudo, T | 1 |
| Ishihara, H | 1 |
| Matsuki, A | 1 |
6 other studies available for olprinone and Pulmonary Hypertension
| Article | Year |
|---|---|
[Comparison of the effects of phosphodiesterase III inhibitors, milrinone and olprinone, in infant corrective cardiac surgery].
Topics: Cardiac Surgical Procedures; Female; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Hypert | 2013 |
A specific and sensitive HPLC-MS/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients.
Topics: Administration, Inhalation; Cardiopulmonary Bypass; Chemical Fractionation; Chromatography, High Pre | 2014 |
[Anesthetic management of a patient with pulmonary hypertension due to a large anterior mediastinal tumor anticipated by preoperative computed tomography].
Topics: Aged; Alprostadil; Anesthesia, General; Humans; Hypertension, Pulmonary; Imidazoles; Male; Mediastin | 2012 |
[Anesthetic management for an infant with tetralogy of fallot with absent pulmonary valve].
Topics: Alprostadil; Anesthesia; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Fe | 2005 |
Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension.
Topics: Animals; Blood Gas Analysis; Cardiac Output; Cardiotonic Agents; Dogs; Hemodynamics; Hypertension, P | 2000 |
A comparison of the spasmolytic effects of olprinone and aminophylline on serotonin-induced pulmonary hypertension and bronchoconstriction with or without beta-blockade in dogs.
Topics: Adrenergic beta-Antagonists; Aminophylline; Animals; Bronchoconstriction; Bronchodilator Agents; Dog | 2000 |